Capillary Leak Syndrome

PharmAbcine’s Study Highlights PMC-403’s Potential in Preclinical Models of Capillary Leak Syndrome

PharmAbcine, a clinical-stage biotech company, has published a study in Science Advances showcasing the potential of its Tie2-activating antibody program,…